Health Care: Drugs

Pluristem Therapeutics Inc (PSTI: NASDAQ)

$2.93 -0.04 | -1.35%
09/18/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 2.97
52 Week High 4.63
52 Week Low 2.58
Avg. Daily Vol. (Mil) 0.10
Beta (3 year) 0.79
Share Related Items
Mkt Cap (Mil) 205.76
Shares Out (Mil) 69.28
Float (Mil) 65.25
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 7.60
Current Ratio 8.40
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 542.89
Price/Book 3.31
Price/Cash Flow -8.70
Per Share Data
Earnings -0.42
Sales 0.01
Book Value 0.90
Cash Flow -0.34
Business Summary
Pluristem Therapeutics Inc is a bio-therapeutics company. It is engaged in developing off-the-shelf allogeneic cell therapy products for treatment of ischemic & inflammatory, cardiovascular, orthopedic, pulmonary, hematological, & women's health diseases.
General Information
MATAM Advanced Technology Pa
Building No 5, No 20
Haifa, 31905
www.pluristem.com
Industry : Drugs
Sector: Health Care
Employees: 160
CEO: Zami Aberman
Short Interest
Current Month (Mil) 0.35
Previous Month (Mil) 0.35
Short Interest Ratio (Days) 3.70
Management Effectiveness
Return on Equity n.a.
Return on Assets -36.40
Return on Investments -43.40
Profitability
Gross Margin 97.10
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with PSTI

Latest PSTI Headlines from TheStreet

More Financial News for PSTI

Press Releases for PSTI

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter